<?xml version="1.0" encoding="UTF-8"?>
<p>Various studies worldwide stated that hospitalized, ill coronavirus disease 2019 (COVID-19) patients are frequently developing laboratory abnormalities compatible with a state of hypercoagulability and clinically a high prevalence of thromboembolic events (
 <xref rid="B5" ref-type="bibr">5</xref>). Ranucci et al. (
 <xref rid="B1" ref-type="bibr">1</xref>) recently reported a coagulation analyses including d-dimers, fibrinogen levels, in the COVID-19 patients, and reported the procoagulant profile on ICU admission with median d-dimer levels 10 times the upper limit of normal (5.5 mg/L).
</p>
